This week’s journal club discusses a landmark first-in-human study published in Cell (2024) investigating autologous transplantation of chemically induced pluripotent stem cell-derived islets (CiPSC-islets) for type 1 diabetes (T1D).
Camille Belliard, currently pursuing an engineering degree in biotechnology at ENSTBB (Bordeaux INP), started a 4-months summer internship in our lab (June-September 2025). She will work with Lucas and Agnes on reprogramming T1D patient fibroblasts into iPSC and their differentiation…